Terilyn J. Monroe - 15 Jan 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief People Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Tarilyn J. Monroe
Issuer symbol
GH
Transactions as of
15 Jan 2025
Net transactions value
-$240,750
Form type
4
Filing time
16 Jan 2025, 17:04:29 UTC
Previous filing
12 Nov 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +17,378 +1792% $0.000000 18,348 15 Jan 2025 Direct
transaction GH Common Stock Tax liability $240,750 -6,420 -35% $37.50 11,928 15 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -17,378 -33% $0.000000 34,758 15 Jan 2025 Common Stock 17,378 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This represents a restricted stock unit award granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on the one-year anniversary of January 15, 2024 and the remaining 67% of the shares vests annually over the remaining two-year period thereafter.
F3 Not applicable for Restricted Stock Units.

Remarks:

Table I includes 970 shares acquired under Guardant Health's Employee Stock Purchase Plan on 11/14/2024.